BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9420975)

  • 21. [Acquired neuromuscular weakness : underestimated problem in intensive care medicine].
    Krebs M; Weber-Carstens S
    Anaesthesist; 2011 Oct; 60(10):885-6. PubMed ID: 22006116
    [No Abstract]   [Full Text] [Related]  

  • 22. Electrophysiologic techniques in critical illness-associated weakness.
    Trojaborg W
    J Neurol Sci; 2006 Mar; 242(1-2):83-5. PubMed ID: 16412474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional recovery after neuromuscular blockade in mechanically ventilated critically ill patients.
    Whetstone Foster JG; Clark AP
    Heart Lung; 2006; 35(3):178-89. PubMed ID: 16701112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology, selection and complications associated with neuromuscular blocking drugs in ICU patients.
    Prielipp RC
    Yale J Biol Med; 1998; 71(6):469-84. PubMed ID: 10604780
    [No Abstract]   [Full Text] [Related]  

  • 25. [Convalescence and decline in physical function level following intensive therapy].
    Poulsen JB; Møller K; Perner A
    Ugeskr Laeger; 2009 Sep; 171(40):2916-9. PubMed ID: 19814942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse responses: sedation, analgesia and neuromuscular blocking agents in critically ill children.
    Sorce LR
    Crit Care Nurs Clin North Am; 2005 Dec; 17(4):441-50, xi-xii. PubMed ID: 16344213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical illness neuromuscular syndromes.
    De Jonghe B; Lacherade JC; Durand MC; Sharshar T
    Crit Care Clin; 2006 Oct; 22(4):805-18; abstract xi. PubMed ID: 17239756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of neuromuscular blockade in the critically ill patient.
    Michaud D; Abbas M; Gélinas C
    Dynamics; 2002; 13(3):11. PubMed ID: 12640839
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of muscle relaxants in the intensive care unit.
    Booij LH
    Acta Anaesthesiol Belg; 1997; 48(1):35-44. PubMed ID: 9099307
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuromuscular complications of sepsis.
    Bolton CF
    Intensive Care Med; 1993; 19 Suppl 2():S58-63. PubMed ID: 8106679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical illness neuromuscular syndromes.
    De Jonghe B; Lacherade JC; Durand MC; Sharshar T
    Neurol Clin; 2008 May; 26(2):507-20, ix. PubMed ID: 18514824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blockade of the ion channels of the skeletal muscle acetylcholine receptor].
    Danilov AF
    Eksp Klin Farmakol; 1998; 61(6):73-5. PubMed ID: 9929824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Physical and neuropsychological sequelae after intensive therapy].
    Kancir CB; Fonsmark L
    Ugeskr Laeger; 2007 Feb; 169(8):697-9. PubMed ID: 17313919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical illness polyneuropathy and myopathy: do they persist for lifetime?
    Bogdanski R; Blobner M; Werner C
    Crit Care Med; 2003 Apr; 31(4):1279-80. PubMed ID: 12682506
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuromuscular complications of sepsis in children.
    Sheth RD; Bolton CF
    J Child Neurol; 1995 Sep; 10(5):346-52. PubMed ID: 7499753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease.
    Balice-Gordon RJ; Smith DB; Goldman J; Cork LC; Shirley A; Cope TC; Pinter MJ
    Ann Neurol; 2000 May; 47(5):596-605. PubMed ID: 10805330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical illness neuromyopathy and muscle weakness in patients in the intensive care unit.
    Fan E; Zanni JM; Dennison CR; Lepre SJ; Needham DM
    AACN Adv Crit Care; 2009; 20(3):243-53. PubMed ID: 19638746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle.
    Kuwabara S; Misawa S; Takahashi H; Sawai S; Kanai K; Nakata M; Mori M; Hattori T; Yuki N
    J Neuroimmunol; 2007 Sep; 189(1-2):158-62. PubMed ID: 17673301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness.
    Fletcher SN; Kennedy DD; Ghosh IR; Misra VP; Kiff K; Coakley JH; Hinds CJ
    Crit Care Med; 2003 Apr; 31(4):1012-6. PubMed ID: 12682465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute weakness syndromes in critically ill patients--a reappraisal.
    Nates JL; Cooper DJ; Day B; Tuxen DV
    Anaesth Intensive Care; 1997 Oct; 25(5):502-13. PubMed ID: 9352763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.